Specialty Pharmacy

Tracking a particular anti-tumor necrosis factor (TNF) through the body can help determine an effective RA dose.

Visionary health care executives selected to take helm of NASP.

Abbreviated new drug applications were accepted for 3 topical generic products on December 30, 2016.

Certain protease inhibitors linked to cognitive issues.

Resetting the Gut Microbiome Offers Potential Treatment for Rare Autoimmune Disease

Aspirin may serve as a preventive measure for pancreatic cancer development.

Certain hypertension drugs block breast and pancreatic cancer invasion.

Top news of the day from across the health care landscape.

Cancer accounts for more years of life lost than any other cause of death.

Pharmacists most frequently become the formal and informal leaders for the specialty pharmacies they work in.

Two-drug combination with rilpivirine and dolutegravir demonstrated non-inferiority to other HIV regimens.

A toxin in bee venom may put an end to HIV in the future.

Top news of the day from across the health care landscape.

The FDA approved nusinersen (Spinraza) for the treatment of patients with spinal muscular atrophy.

The rule builds on the FDA’s ongoing effort to encourage complete postmarketing safety data on various biologic and device products.

Both combination product applicants and constituent part applicants are required to comply with postmarketing safety reporting rules.

Most quality indicators for diabetes care monitor risk factors to see if patients are reaching their target levels.

FDA proposal would add 6 bulk drug substances and remove 4 substances that can be used in compounding.

Revisions would add 6 bulk drug substances and remove 4 substances that can be used in compounding.

Top articles of the year on Specialty Pharmacy Times.

A new survey reveals patients are concerned about costs, but largely unaware of health plan benefits.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies can best demonstrate value as health care transitions to a value-based system.

Reduced reimbursements, Medicare Part D, and the Affordable Care Act have stimulated pharmacies to offer a broader palette of services.

Biosimilar erythropoiesis-stimulating agent epoetin was well-tolerated and efficacious in the treatment of geriatric patients with chemotherapy-induced anemia.

Smaller co-payments for prescription drugs leaves individuals less likely to visit the hospital.

Top oncology articles of 2016 on Specialty Pharmacy Times.

New cancer-spreading protein discovered in groundbreaking study.

Relapsed or refractory leukemia patients who received CC-486 had a 38% overall response rate.